Delivery Order SPE2DB22D2206-SPE2DB25FHG71
Award Date 6/5/25
Potential Completion Date 6/27/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of ONIVYDE 43 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $5,345.67 and is scheduled for completion by September 17, 2025. ONIVYDE is a chemotherapy medication used primarily in cancer treatment regimens. The award represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,691.34 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 ml vials on April 24, 2025, with an ultimate completion date of May 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Onivyde is a specialized oncology medication used in cancer treatment, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of ONIVYDE 43 mg/10 ml vials valued at $5,345.67 with a firm fixed price structure. This non-set-aside delivery order is scheduled for ultimate completion by July 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of ONIVYDE 43 mg/10 mL vials valued at $10,691.34. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, with performance to be completed at the vendor's Conshohocken, Pennsylvania location. The award represents a non-competitive, non-set-aside delivery order, indicating it was issued under an existing contract vehicle rather than...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Onivyde (irinotecan liposomal) 43 mg/10 mL vials at a ceiling value of $10,691.34. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion by October 1, 2025, and performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $10,691.34 to AmerisourceBergen Drug Corp for the supply of Onivyde 43 mg/10 ml vials on August 28, 2025, with an ultimate completion date of September 19, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for ONIVYDE 43 mg/10 ml vials, valued at $10,691.34 under a firm fixed price contract type. The award was made on September 23, 2025, with an ultimate completion date of October 15, 2025, and the work will be performed at the contractor's location in Conshohocken, Pennsylvania. This non-competitive delivery order draws from AmerisourceBergen's existing Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $5,345.67 and a performance period through June 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a specialty pharmaceutical product, with a potential value of $8,427.00 and a completion date of February 23, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), to supply ONIVYDE 43 MG/10 ML VIAL 10ML, a specialty pharmaceutical product, with a ceiling value of $16,854.00 and a period of performance through April 10, 2024. This delivery order was placed under an existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp,...